164 related articles for article (PubMed ID: 16984379)
1. Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: an important autocrine/paracrine factor in tumor progression.
Kikuchi N; Horiuchi A; Osada R; Imai T; Wang C; Chen X; Konishi I
Cancer Sci; 2006 Oct; 97(10):1061-9. PubMed ID: 16984379
[TBL] [Abstract][Full Text] [Related]
2. Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites.
Maelandsmo GM; Flørenes VA; Nguyen MT; Flatmark K; Davidson B
Tumour Biol; 2009; 30(1):15-25. PubMed ID: 19194111
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.
Horiuchi A; Hayashi T; Kikuchi N; Hayashi A; Fuseya C; Shiozawa T; Konishi I
Int J Cancer; 2012 Oct; 131(8):1755-67. PubMed ID: 22287060
[TBL] [Abstract][Full Text] [Related]
4. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
5. Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization.
Fabris L; Cadamuro M; Moserle L; Dziura J; Cong X; Sambado L; Nardo G; Sonzogni A; Colledan M; Furlanetto A; Bassi N; Massani M; Cillo U; Mescoli C; Indraccolo S; Rugge M; Okolicsanyi L; Strazzabosco M
Hepatology; 2011 Sep; 54(3):890-9. PubMed ID: 21618579
[TBL] [Abstract][Full Text] [Related]
6. [Nuclear expression of S100A4 is associated with lymph node metastasis in gastric carcinoma].
Zhong XY; Zhang LH; Jia SQ; Shi T; DU H; Hu Y; Zhang GG; Lu AP; Li JY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):454-7. PubMed ID: 17851788
[TBL] [Abstract][Full Text] [Related]
7. S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma.
Hiruta A; Oguri Y; Yokoi A; Matsumoto T; Oda Y; Tomohiro M; Hashimura M; Jiang Z; Tochimoto M; Nakagawa M; Saegusa M
Am J Pathol; 2020 Nov; 190(11):2304-2316. PubMed ID: 32805233
[TBL] [Abstract][Full Text] [Related]
8. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylation-induced expression of S100A4 in endometrial carcinoma.
Xie R; Loose DS; Shipley GL; Xie S; Bassett RL; Broaddus RR
Mod Pathol; 2007 Oct; 20(10):1045-54. PubMed ID: 17673926
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.
Cadamuro M; Spagnuolo G; Sambado L; Indraccolo S; Nardo G; Rosato A; Brivio S; Caslini C; Stecca T; Massani M; Bassi N; Novelli E; Spirli C; Fabris L; Strazzabosco M
Cancer Res; 2016 Aug; 76(16):4775-84. PubMed ID: 27328733
[TBL] [Abstract][Full Text] [Related]
11. Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer.
Kim JH; Kim CN; Kim SY; Lee JS; Cho D; Kim JW; Yoon SY
Oncol Rep; 2009 Jul; 22(1):41-7. PubMed ID: 19513503
[TBL] [Abstract][Full Text] [Related]
12. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
13. Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts.
Radestock Y; Willing C; Kehlen A; Hoang-Vu C; Hombach-Klonisch S
Mol Cancer Res; 2010 Apr; 8(4):494-506. PubMed ID: 20332215
[TBL] [Abstract][Full Text] [Related]
14. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
Noske A; Weichert W; Niesporek S; Röske A; Buckendahl AC; Koch I; Sehouli J; Dietel M; Denkert C
Cancer; 2008 Apr; 112(8):1733-43. PubMed ID: 18306389
[TBL] [Abstract][Full Text] [Related]
15. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
16. S100A4 expression is an early event of papillary carcinoma of the thyroid.
Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
Oncology; 2004; 67(5-6):397-402. PubMed ID: 15713996
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM
Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579
[TBL] [Abstract][Full Text] [Related]
18. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of S100A4 as a biomarker of metastasis and recurrence in oral squamous cell carcinoma.
Natarajan J; Hunter K; Mutalik VS; Radhakrishnan R
J Appl Oral Sci; 2014; 22(5):426-33. PubMed ID: 25466476
[TBL] [Abstract][Full Text] [Related]
20. Correlation of S100A4 expression with invasion and metastasis in oral squamous cell carcinoma.
Moriyama-Kita M; Endo Y; Yonemura Y; Heizmann CW; Schäfer BW; Sasaki T; Yamamoto E
Oral Oncol; 2004 May; 40(5):496-500. PubMed ID: 15006621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
